A randomized, double-blind, placebo-controlled cross over trial of the effect on quality of life (QOL) of continuing dexamethasone beyond 24 hours following moderately emetogenic chemotherapy in women with breast cancer

Abstract only

Saved in:

Bibliographic Details
Published in	Journal of clinical oncology Vol. 29; no. 15_suppl; p. 9020
Main Authors	Vardy, J. L., Pond, G. R., Dodd, A., Warr, D., Seruga, B., Clemons, M. J., Bordeleau, L., Tannock, I.
Format	Journal Article
Language	English
Published	20.05.2011
Online Access	Get full text

Loading…